Teva refiles long-acting schizophrenia drug after FDA rejection
Teva, Eagle Pharmaceuticals cancer therapy approved by FDA - Philadelphia Business Journal
FDA clears Teva's tardive dyskinesia drug Austedo - PMLiVE
Teva months from restarting production at Hungary plant banned by US FDA
FDA Approval Letter - Teva Pharmaceuticals
Teva Hits FDA Hurdle, Slips 4.5% Pre-Market - TipRanks.com
Teva Receives FDA Approval for Migraine Autoinjector | Ctech
Teva Pharmaceutical's AirDuo Digihaler gets FDA green light | MobiHealthNews
Celltrion FDA warning causes headache for Teva's biologics ambition
FDA warns of Adderall shortage after Teva manufacturing delay - YouTube
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
FDA Warning Letter Reveals Data and Sterility Issues at Teva Plant in Hungary | RAPS
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay | Fierce Pharma
FDA Rejection Cuts Off Teva Pharmaceutical Stock's Rally
Teva's digital inhaler cleared by FDA | MobiHealthNews
TEVA: Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector | FDA Health News
Teva files potential blockbuster migraine drug for FDA approval
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
FDA accepts Teva-MedinCell's new drug application for schizophrenia drug
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
FDA Roundup AstraZeneca Teva Amgen And More
FDA delays approval for Teva schizophrenia drug - גלובס
FDA warns of Adderall shortage after Teva manufacturing delay
Teva confirms US FDA warning letter for Hangzhou, China API plant
